These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 11135728

  • 1. Evidence for susceptibility to malignant hyperthermia in patients with exercise-induced rhabdomyolysis.
    Wappler F, Fiege M, Steinfath M, Agarwal K, Scholz J, Singh S, Matschke J, Schulte Am Esch J.
    Anesthesiology; 2001 Jan; 94(1):95-100. PubMed ID: 11135728
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Malignant hyperthermia (MH) diagnostics: a comparison between the halothane-caffeine- and the ryanodine-contracture-test results in MH susceptible, normal and control muscle.
    Hartung E, Koob M, Anetseder M, Schoemig P, Krauspe R, Hogrefe G, Engelhardt W.
    Acta Anaesthesiol Scand; 1996 Apr; 40(4):437-44. PubMed ID: 8738688
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of the segregation of the RYR1 C1840T mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family.
    Serfas KD, Bose D, Patel L, Wrogemann K, Phillips MS, MacLennan DH, Greenberg CR.
    Anesthesiology; 1996 Feb; 84(2):322-9. PubMed ID: 8602662
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mutation screening in the ryanodine receptor 1 gene (RYR1) in patients susceptible to malignant hyperthermia who show definite IVCT results: identification of three novel mutations.
    Rueffert H, Olthoff D, Deutrich C, Meinecke CD, Froster UG.
    Acta Anaesthesiol Scand; 2002 Jul; 46(6):692-8. PubMed ID: 12059893
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Predictive factors of the contracture test for diagnosing malignant hyperthermia in a Brazilian population sample: a retrospective observational study.
    de Mello JM, Andrade PV, Santos JM, Oliveira ASB, Vainzof M, do Amaral JLG, Almeida da Silva HC.
    Braz J Anesthesiol; 2023 Jul; 73(2):145-152. PubMed ID: 35835312
    [Abstract] [Full Text] [Related]

  • 15. [Diagnosis of malignant hyperthermia susceptibility. 1. The significance of in vitro susceptibility tests].
    Mortier W, Breucking E.
    Anaesthesist; 1993 Oct; 42(10):675-83. PubMed ID: 8250201
    [Abstract] [Full Text] [Related]

  • 16. Masseter muscle rigidity and the role of DNA analysis to confirm malignant hyperthermia susceptibility.
    Hudig K, Pollock N, Bulger T, Machon RG, Woodhead A, Schiemann AH, Stowell KM.
    Anaesth Intensive Care; 2019 Jan; 47(1):60-68. PubMed ID: 30864471
    [Abstract] [Full Text] [Related]

  • 17. Inositol 1,4,5-trisphosphate synthesis in mononuclear white blood cells of malignant hyperthermia-susceptible and normal human beings, following in vitro exposure to halothane, caffeine and ryanodine.
    Martens U, Krause T, Scholz J, Wappler F, Steinrücke K, am Esch JS.
    Eur J Anaesthesiol; 2000 Jun; 17(6):364-72. PubMed ID: 10928436
    [Abstract] [Full Text] [Related]

  • 18. Is there a link between exertional heat stroke and susceptibility to malignant hyperthermia?
    Sagui E, Montigon C, Abriat A, Jouvion A, Duron-Martinaud S, Canini F, Zagnoli F, Bendahan D, Figarella-Branger D, Brégigeon M, Brosset C.
    PLoS One; 2015 Jun; 10(8):e0135496. PubMed ID: 26258863
    [Abstract] [Full Text] [Related]

  • 19. Molecular genetic testing for malignant hyperthermia susceptibility.
    Girard T, Treves S, Voronkov E, Siegemund M, Urwyler A.
    Anesthesiology; 2004 May; 100(5):1076-80. PubMed ID: 15114203
    [Abstract] [Full Text] [Related]

  • 20. Sevoflurane is less sensitive than halothane for in vitro detection of malignant hyperthermia susceptibility.
    Johannsen S, Klingler W, Schneiderbanger D, Heiderich S, Roewer N, Schuster F.
    Acta Anaesthesiol Scand; 2013 Oct; 57(9):1161-6. PubMed ID: 23957432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.